本文旨在比较促动力药西沙必利(cisapride)、H_2受体拮抗剂雷尼替丁及两者联用对胃溃疡患者溃疡愈合的效果。 病人和方法:将60例门诊初次诊断为无并发症的胃窦部溃疡病人随机分三组:西沙必利组(C 20mg bid)、雷尼替丁组(R150mg bid)和西沙必利加雷尼替丁组(C+R)。剔除了多发性溃疡(3个溃疡以上者)及复合性溃疡、妊娠妇女、糖尿病、胃肠道手术史、胶原病及慢 This article aims to compare the effects of the propofol cisapride and the H 2 receptor antagonist ranitidine and their combination on ulcer healing in patients with gastric ulcer. Patients and Methods: A total of 60 outpatients with gastric ulcer were randomly divided into three groups: Cisplatin (20 mg bid), ranitidine (R150 mg bid) and cisapride plus Rare Ding group (C + R). Excluding multiple ulcers (more than 3 ulcers) and complex ulcers, pregnant women, diabetes, gastrointestinal surgery, collagen disease and slow